Completed NA INTERVENTIONAL 1-arm NCT00870077

A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease (PROTOB)

Effect of a Whey Protein Supplementation on Intrahepatic Lipids in Obese Patients With Non-alcoholic Fatty Liver Disease

Sponsor: University of Lausanne

Conditions Non-alcoholic Fatty Liver Disease Obesity

Interventions ProWHEY 94 CFM, SponserR

Updated 5 times since 2017 Last updated: Feb 23, 2012 Started: Apr 30, 2009 Primary completion: Dec 31, 2009 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00870077, this NA trial focuses on Non-alcoholic Fatty Liver Disease and Obesity and remains completed. Sponsored by University of Lausanne, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Lausanne

Data source: University of Lausanne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lausanne, Switzerland